Postoperative IHC results of the laryngeal tumor were as follows: CD20 (+), CD79a (+), CD3 (−), CD10 (−), Bcl-2 (+), CD5 (−), Cyclin D1 (−), and CD23 (−). This evidence concerns the gene BCL2 and laryngeal neoplasm.